| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d690f6ce8319a370dd847ab0d17121d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7b61bd418bcb396931bde18ca63fc2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9efd31f272e485019516d985b1a74de2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf5541c77a5aae03018b8e64123355ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13d4f676df9d3f69f2560cc184a1c9e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_489a729b500d808f263300d1e680107c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06 |
| filingDate |
2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a41dbcfd47ebaba6bbc0acf03bc01aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_931a1f71125b8222863528aef1ce35b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caa5d2859bad03cd91c3eb61ef1fcbad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17da8ad38ba7bf114135b932ff0791d3 |
| publicationDate |
2007-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007045691-A2 |
| titleOfInvention |
Renal carcinoma cell line and use thereof |
| abstract |
The present invention relates to a renal carcinoma cell line capable of activating the immune system in an antigen-specific manner. According to a further aspect, the invention also includes derivatives of the cell line that maintain said activation capacity. The invention also comprises a method for targeting and activating immune system cells against cells of clear cell renal carcinoma. Said method comprises the co-incubation of isolated immune system cells (dendritic cells, CD4*, CD8* lymphocytes etc.) with cells of the RCC BA85#21 line in accordance with the invention in a suitable culture medium, for a time sufficient to obtain antigen specific cells. |
| priorityDate |
2005-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |